SDA
- Product code
- SDA
- Device name
- Electrical Tumor Treatment Fields For Non-Small Cell Lung Cancer
- Device class
- Class 3
- Medical specialty
- Unknown
- Marketing pathway
- PMA
- Flag
- Life-sustaining / life-supporting
FDA classification definition
Optune Lua concurrent with PD-1/PD-L1 inhibitors or docetaxel is indicated for adult patients with metastatic non-small cell lung cancer who have progressed on or after a platinum-based regimen.
Official FDA classification page: SDA
Classification and pathway per current FDA publications. Data from openFDA (CC0).